| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |